Levitz Michael L's Form 4 filing
Anika Therapeutics, Inc. (ANIK) · filed Aug 13, 2021
- Accession no.
- 0001171843-21-005933
- Filed
- Aug 13, 2021
- Trade date
- Aug 11-12, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market purchases total $145.8K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Levitz Michael LCIK 0001468019 | Officer (EVP, CFO, Treasurer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
On August 11, 2021, Mr. Levitz purchased 2,850 shares in multiple trades ranging from $39.85 to $40.50. The price reported above reflects the weighted average purchase price. Mr. Levitz undertakes to provide the Securities and Exchange Commission staff, the issuer, or any security holder, upon request, full information regarding the number of shares and prices at which the transactions were effected.
Referenced by the price of 1 transaction in Table I.
- F2
On August 12, 2021, Mr. Levitz purchased 777 shares in multiple trades ranging from $40.07 to $40.41. The price reported above reflects the weighted average purchase price. Mr. Levitz undertakes to provide the Securities and Exchange Commission staff, the issuer, or any security holder, upon request, full information regarding the number of shares and prices at which the transactions were effected.
Referenced by the price of 1 transaction in Table I.